Amfepentorex
From Wikipedia, the free encyclopedia
|
Amfepentorex
|
|
| Systematic (IUPAC) name | |
| N-methyl-1-(4-pentylphenyl)propan-2-amine | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C15H25N |
| Mol. mass | 219.366 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Amfepentorex is a stimulant drug derived from amphetamine, which is used as an appetite suppressant for the treatment of obesity. Dosage is 50-100mg per day. Side effects include insomnia, hypertension and acute glaucoma.[1]
Compounding of amfepentorex formulations is illegal in France.[1]

